Publications

The sustained release of the acetylcholinesterase inhibitor ZT-1 confers the potential for a more efficient neuroprotection in rats

Phase IIa Clinical Study of a New Human Neutrophil Elastase Inhibitor, EPI-hNE4 (DX890), with repeated Administration by Inhalation in Adult…

H3 Pharma receives Orphan-drug designation from the FDA for: monoclonal antibody SC-1, in gastric cancer

Comparative Efficacy of Triptorelin Pamoate and Leuprolide Acetate in Men with Advanced Prostate Cancer

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer

Characteristics of EPI-hNE4 Aerosol: A New Elastase Inhibitor for Treatment of Cystic Fibrosis

The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s…

The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s…